Harlan Robins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Harlan Robins has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Marissa Vignali
Adaptive Biotechnologies
6 shared publications Cindy Desmarais
Adaptive Biotechnologies, Seattle, Washington, USA
5 shared publications- Ryan O. Emerson
Adaptive Biotechnologies, Seattle, WA
5 shared publications Christopher S. Carlson
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, Washington 98109, USA
4 shared publicationsRyan O. Emerson
Adaptive Biotechnologies, Seattle, Washington, USA
4 shared publicationsAnna M. Sherwood
Adaptive Biotechnologies, 1551 Eastlake Ave E, Seattle, Washington 98102, USA
3 shared publications
Latest Publications
- Open Access
- 16 November 2018
- Published by Adaptive Biotechnologies
A public database of memory and naive B-cell receptor sequences
Open-access immunosequencing data | Robins, Harlan | PLOS ONE | Adaptive Biotechnologies | The vast diversity of B-cell receptors (BCR) and secreted antibodies enables the recognition of, and response to, a wide range of epitopes, but this diversity has also limited our understanding of humoral immunity. We present a public database of more than 37 million unique BCR sequences from three healthy adult donors that is many fold deeper than any existing resource, together with a set of online tools designed to facilitate the visualization and analysis of the annotated data. We estimate the clonal diversity of the naive and memory B-cell repertoires of healthy individuals, and provide a set of examples that illustrate the utility of the database, including several views of the basic properties of immunoglobulin heavy chain sequences, such as rearrangement length, subunit usage, and somatic hypermutation positions and dynamics.Since this dataset is very large, instead of using the "Export Data' button on the orange box to the right, to download the underlying data please go to:https://s3-us-west-2.amazonaws.com/publishedproject-supplements/brr/public-bcell-dataset.tgzfor a zipped file.
- 16 November 2018
- Published by Adaptive Biotechnologies
Open AccessA public database of memory and naive B-cell receptor sequences
Open-access immunosequencing data | Robins, Harlan | PLOS ONE | Adaptive Biotechnologies | The vast diversity of B-cell receptors (BCR) and secreted antibodies enables the recognition of, and response to, a wide range of epitopes, but this diversity has also limited our understanding of humoral immunity. We present a public database of more than 37 million unique BCR sequences from three healthy adult donors that is many fold deeper than any existing resource, together with a set of online tools designed to facilitate the visualization and analysis of the annotated data. We estimate the clonal diversity of the naive and memory B-cell repertoires of healthy individuals, and provide a set of examples that illustrate the utility of the database, including several views of the basic properties of immunoglobulin heavy chain sequences, such as rearrangement length, subunit usage, and somatic hypermutation positions and dynamics.Since this dataset is very large, instead of using the "Export Data' button on the orange box to the right, to download the underlying data please go to:https://s3-us-west-2.amazonaws.com/publishedproject-supplements/brr/public-bcell-dataset.tgzfor a zipped file.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , 11500
TCR repertoire sequencing of 254 resected non-small cell lung cancers to reveal TCR clonality in normal tissues compared to tumor tissues.
11500 Background: The mechanisms underlying resistance to immune checkpoint blockade are poorly understood. Major efforts have been made to understand how mutations, through generation of neoantigens, may alter tumor immunogenicity and anti-tumor responses, particularly through T cell responses. However, the T cell repertoire and its interaction with cancers bearing specific molecular alterations have not been systemically studied. Methods: We delineated the landscapes in the T cell receptor (TCR) repertoire, immune infiltration (immunohistochemistry using multiple immune markers), genome (exome sequencing), epigenome (methylation array) and transcriptome (mRNA gene expression array) of 254 resected non-small cell lung cancers (NSCLC), matched normal lung tissues and peripheral blood mononuclear cells (PBMC). We report herein the preliminary analyses of TCR sequencing of NSCLC tumors and matched normal lung tissues. Results: We observed that: 1) Smaller tumors (smaller than median) had a higher T cell infiltrate (p = 0.0016) and higher entropy than larger tumors (p = 0.0098); 2) Tumors from ever/current smokers had higher T cell clonality than former/never-smokers (p = 0.005); 3) TCR clonality was positively correlated with mutational burden (p = 0.0026); 4) Compared to tumors, normal lung tissues demonstrated significantly less T cell infiltration (p = 2.1x10^-11), but a significantly higher clonality (p = 3.9x10^-7). Finally, many T cell clones, including major clones were shared between normal lung tissues and matched NSCLC tumors. Conclusions: Our preliminary data demonstrate the distinct immune microenvironment in different NSCLC tumors may be associated with particular clinicopathological features. The higher TCR clonality in normal lung tissues and overlap of T cell clones between normal lung and NSCLC tumors implies a significant proportion of tumor infiltrating T cells may be a function of constant exposure to mutagens rather than an anti-tumor response. Analysis of the peripheral TCR repertoire, the molecular landscape of these tumors and the association with immune profiling is underway.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , 11500
TCR repertoire sequencing of 254 resected non-small cell lung cancers to reveal TCR clonality in normal tissues compared to tumor tissues.
11500 Background: The mechanisms underlying resistance to immune checkpoint blockade are poorly understood. Major efforts have been made to understand how mutations, through generation of neoantigens, may alter tumor immunogenicity and anti-tumor responses, particularly through T cell responses. However, the T cell repertoire and its interaction with cancers bearing specific molecular alterations have not been systemically studied. Methods: We delineated the landscapes in the T cell receptor (TCR) repertoire, immune infiltration (immunohistochemistry using multiple immune markers), genome (exome sequencing), epigenome (methylation array) and transcriptome (mRNA gene expression array) of 254 resected non-small cell lung cancers (NSCLC), matched normal lung tissues and peripheral blood mononuclear cells (PBMC). We report herein the preliminary analyses of TCR sequencing of NSCLC tumors and matched normal lung tissues. Results: We observed that: 1) Smaller tumors (smaller than median) had a higher T cell infiltrate (p = 0.0016) and higher entropy than larger tumors (p = 0.0098); 2) Tumors from ever/current smokers had higher T cell clonality than former/never-smokers (p = 0.005); 3) TCR clonality was positively correlated with mutational burden (p = 0.0026); 4) Compared to tumors, normal lung tissues demonstrated significantly less T cell infiltration (p = 2.1x10^-11), but a significantly higher clonality (p = 3.9x10^-7). Finally, many T cell clones, including major clones were shared between normal lung tissues and matched NSCLC tumors. Conclusions: Our preliminary data demonstrate the distinct immune microenvironment in different NSCLC tumors may be associated with particular clinicopathological features. The higher TCR clonality in normal lung tissues and overlap of T cell clones between normal lung and NSCLC tumors implies a significant proportion of tumor infiltrating T cells may be a function of constant exposure to mutagens rather than an anti-tumor response. Analysis of the peripheral TCR repertoire, the molecular landscape of these tumors and the association with immune profiling is underway.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e15133
Similar T-cell repertoires of tumor infiltrating lymphocytes and Crohn’s-like lymphoid reaction in colorectal cancer.
E15133 Background: Tumor infiltrating lymphocytes (TILs) and Crohn’s-like Lymphoid Reaction (CLR) are independently associated with improved survival in colorectal cancer (CRC). Whereas TILs are localized within tumors, CLR are extra-tumoral lymphocytic aggregates. The origins and relationships of the T-cell repertoire of TILs and the T cells within CLR of the colorectal cancer tumor microenvironment are unknown. Methods: Expert pathology review identified and circled areas of invasive adenocarcinoma and areas containing CLR from 13 CRC patients for macrodissection from formalin fixed paraffin embedded (FFPE) slides. DNA was extracted from matched tumor and CLR areas for multiplex PCR sequencing of the CDR3 region of the T-cell receptor beta chain (TCRβ), using the immunoSEQ platform. This approach permits 1) estimating the T-cell content of each sample, 2) measuring the clonality of the T-cell repertoire as a measure of diversity, and 3) quantifying the overlap and similarity of T-cell repertoires across samples. Results: The T-cell content (Spearman’s rs = 0.56, p = 0.046) and clonality (Spearman’s rs = 0.66, p = 0.014) were highly correlated among matched tumor and CLR samples. The ten most frequently identified TIL clones were found at similar frequencies in matched CLR enriched tissues. Comparisons of all the clones detected in tumor and matched CLR tissue demonstrated substantial similarity of these immune repertoires, with an average of 186 shared clones between samples. This degree of similarity was significantly greater than published reports of the similarity of the T-cell repertoire of colorectal tumors and adjacent normal tissue (p = 1.1e-5). Conclusions: The T-cell repertoire of CLR is highly similar to the tumor infiltrating T-cell repertoire, providing supporting evidence for the hypothesis that tumor-specific antigen presentation and lymphocyte maturation occur within CLR.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e15133
Similar T-cell repertoires of tumor infiltrating lymphocytes and Crohn’s-like lymphoid reaction in colorectal cancer.
E15133 Background: Tumor infiltrating lymphocytes (TILs) and Crohn’s-like Lymphoid Reaction (CLR) are independently associated with improved survival in colorectal cancer (CRC). Whereas TILs are localized within tumors, CLR are extra-tumoral lymphocytic aggregates. The origins and relationships of the T-cell repertoire of TILs and the T cells within CLR of the colorectal cancer tumor microenvironment are unknown. Methods: Expert pathology review identified and circled areas of invasive adenocarcinoma and areas containing CLR from 13 CRC patients for macrodissection from formalin fixed paraffin embedded (FFPE) slides. DNA was extracted from matched tumor and CLR areas for multiplex PCR sequencing of the CDR3 region of the T-cell receptor beta chain (TCRβ), using the immunoSEQ platform. This approach permits 1) estimating the T-cell content of each sample, 2) measuring the clonality of the T-cell repertoire as a measure of diversity, and 3) quantifying the overlap and similarity of T-cell repertoires across samples. Results: The T-cell content (Spearman’s rs = 0.56, p = 0.046) and clonality (Spearman’s rs = 0.66, p = 0.014) were highly correlated among matched tumor and CLR samples. The ten most frequently identified TIL clones were found at similar frequencies in matched CLR enriched tissues. Comparisons of all the clones detected in tumor and matched CLR tissue demonstrated substantial similarity of these immune repertoires, with an average of 186 shared clones between samples. This degree of similarity was significantly greater than published reports of the similarity of the T-cell repertoire of colorectal tumors and adjacent normal tissue (p = 1.1e-5). Conclusions: The T-cell repertoire of CLR is highly similar to the tumor infiltrating T-cell repertoire, providing supporting evidence for the hypothesis that tumor-specific antigen presentation and lymphocyte maturation occur within CLR.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 5546
Prognostic effects of peripheral and tumor-infiltrating T-cell repertoire diversity in ovarian cancer.
5546 Background: While the prognostic value of the number of tumor-infiltrating lymphocytes (TILs) has been demonstrated in many tumor types, the significance of the clonal composition of peripheral and tumor-infiltrating T-cell repertoires is unknown due to challenges in quantifying unique clones. To delineate the impact of the T cell repertoire on anti-tumor immunity, we performed deep T-cell receptor (TCR)-sequencing on paired tumor and peripheral blood samples from 99 ovarian cancer patients. Methods: Clonotype frequencies were calculated for unique TCR-β chain sequences using the ImmunoSEQ platform in 198 total samples. Spontaneous immune responses were evaluated by measuring serum antibodies against ovarian cancer-associated antigens (NY-ESO-1, MAGE-A1, MAGE-A3, p53). The degree of CD3+ and CD8+T-cell infiltration was evaluated by immunohistochemistry. Results: We obtained 505 and 305 million TCR reads (10.3 and 1.4 million unique clones) in peripheral blood and tumors, respectively. Higher clone/CD3 TIL ratios – indicating more diverse repertoires for a given level of infiltration – were associated with poorer OS (HR = 1.7, 95% CI = 1.3-2.4) and PFS (1.7, 1.2-2.3) as were clone/CD4 TIL ratios (OS: 2.6, 1.5-4.4; PFS: 2.3, 1.4-3.7). While higher TIL clonality (scaled 0-1 from polyclonal to monoclonal) conferred a favorable prognosis in patients with spontaneous response to tumor antigens (OS per +0.1: 0.4, 0.1-1.0), it was a poor prognostic factor in patients without a response (1.6, 1.0-2.6). The fraction of peripheral T-cell repertoires that were also present in TIL is positively associated with OS (per +10%, 0.6, 0.4-0.9) and PFS (0.7, 0.5-1.0) in seropositive patients, but is negatively associated in seronegative patients (OS: 1.3, 1.0-1.6; PFS: 1.8, 1.2-2.9). Conclusions: Integration of T-cell repertoire diversity in tumor and peripheral blood with density of TILs identified clone/CD3 TIL and clone/CD4 TIL ratios; TIL clonality; and the degree of overlap of peripheral and TIL repertoire as novel prognostic biomarkers in ovarian cancer. The presence of pre-existing anti-tumor immunity shapes the correlation of TIL clonality and peripheral/TIL overlap with clinical outcome.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 5546
Prognostic effects of peripheral and tumor-infiltrating T-cell repertoire diversity in ovarian cancer.
5546 Background: While the prognostic value of the number of tumor-infiltrating lymphocytes (TILs) has been demonstrated in many tumor types, the significance of the clonal composition of peripheral and tumor-infiltrating T-cell repertoires is unknown due to challenges in quantifying unique clones. To delineate the impact of the T cell repertoire on anti-tumor immunity, we performed deep T-cell receptor (TCR)-sequencing on paired tumor and peripheral blood samples from 99 ovarian cancer patients. Methods: Clonotype frequencies were calculated for unique TCR-β chain sequences using the ImmunoSEQ platform in 198 total samples. Spontaneous immune responses were evaluated by measuring serum antibodies against ovarian cancer-associated antigens (NY-ESO-1, MAGE-A1, MAGE-A3, p53). The degree of CD3+ and CD8+T-cell infiltration was evaluated by immunohistochemistry. Results: We obtained 505 and 305 million TCR reads (10.3 and 1.4 million unique clones) in peripheral blood and tumors, respectively. Higher clone/CD3 TIL ratios – indicating more diverse repertoires for a given level of infiltration – were associated with poorer OS (HR = 1.7, 95% CI = 1.3-2.4) and PFS (1.7, 1.2-2.3) as were clone/CD4 TIL ratios (OS: 2.6, 1.5-4.4; PFS: 2.3, 1.4-3.7). While higher TIL clonality (scaled 0-1 from polyclonal to monoclonal) conferred a favorable prognosis in patients with spontaneous response to tumor antigens (OS per +0.1: 0.4, 0.1-1.0), it was a poor prognostic factor in patients without a response (1.6, 1.0-2.6). The fraction of peripheral T-cell repertoires that were also present in TIL is positively associated with OS (per +10%, 0.6, 0.4-0.9) and PFS (0.7, 0.5-1.0) in seropositive patients, but is negatively associated in seronegative patients (OS: 1.3, 1.0-1.6; PFS: 1.8, 1.2-2.9). Conclusions: Integration of T-cell repertoire diversity in tumor and peripheral blood with density of TILs identified clone/CD3 TIL and clone/CD4 TIL ratios; TIL clonality; and the degree of overlap of peripheral and TIL repertoire as novel prognostic biomarkers in ovarian cancer. The presence of pre-existing anti-tumor immunity shapes the correlation of TIL clonality and peripheral/TIL overlap with clinical outcome.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 3005
Correlation of peripheral and intratumoral T-cell receptor (TCR) clonality with clinical outcomes in patients with metastatic urothelial cancer (mUC) treated with atezolizumab.
3005 Background: The anti-programmed death-ligand 1 (PD-L1) antibody atezolizumab is active in patients (pts) with advanced mUC. We hypothesized that the TCR repertoire in tumors and blood may correlate with clinical benefit. Methods: 29 pts received atezolizumab 1200mg q3w on IMvigor 210 at MSKCC and had specimens available for analysis. High throughput DNA sequencing of the CDR3 region of the TCR beta chain was performed in baseline tumors (N=24) plus pre- and post-treatment peripheral blood mononuclear cells (PBMCs) (N=29 patients, 93 PBMC samples) using the immunoSEQ assay. Clonal dominance, clonal expansion and T-cell fraction were assessed for association with benefit (complete and partial response (CR, PR) vs. stable or progressive disease (SD, PD) and progression-free and overall survival (PFS, OS)). Results: The median number of T cells and unique TCRs sequenced in tumors was 1,402 and 1,085, respectively. The median number of T cells and unique TCRs sequenced in PBMCs was 147,493 and 81,705, respectively.Investigator reported best responses were 5 CR, 2 PR, 5 SD, and 17 PD.A combination of high T cell infiltration and clonality in tumors correlated with CR/PR compared to PD (p=0.02232, OR 11.5). The number of T cell clones in the tumor that expanded in the blood 3 weeks post-treatment was greater in CR/PR than in SD (p=0.01253) or PD pts (p=0.05565). Pts with lower baseline peripheral TCR clonality had improved PFS (p=0.0514) and OS (p=0.0116). Conclusions: In mUC patients treated with atezolizumab, high T cell infiltration and clonality in the tumor plus peripheral expansion of dominant tumor-resident TCR clones were associated with response. Low peripheral TCR clonality was associated with survival. These findings suggest that atezolizumab re-invigorates an oligoclonal population of tumor infiltrating lymphocytes and promotes their expansion in the blood. Low TCR repertoire clonality in the periphery at baseline may aid in preventing immune escape and may lead to improved OS. Similar observations have been seen in mice treated with radiation plus checkpoint blockade (Nature 520:373,2015). These findings warrant further study.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 3005
Correlation of peripheral and intratumoral T-cell receptor (TCR) clonality with clinical outcomes in patients with metastatic urothelial cancer (mUC) treated with atezolizumab.
3005 Background: The anti-programmed death-ligand 1 (PD-L1) antibody atezolizumab is active in patients (pts) with advanced mUC. We hypothesized that the TCR repertoire in tumors and blood may correlate with clinical benefit. Methods: 29 pts received atezolizumab 1200mg q3w on IMvigor 210 at MSKCC and had specimens available for analysis. High throughput DNA sequencing of the CDR3 region of the TCR beta chain was performed in baseline tumors (N=24) plus pre- and post-treatment peripheral blood mononuclear cells (PBMCs) (N=29 patients, 93 PBMC samples) using the immunoSEQ assay. Clonal dominance, clonal expansion and T-cell fraction were assessed for association with benefit (complete and partial response (CR, PR) vs. stable or progressive disease (SD, PD) and progression-free and overall survival (PFS, OS)). Results: The median number of T cells and unique TCRs sequenced in tumors was 1,402 and 1,085, respectively. The median number of T cells and unique TCRs sequenced in PBMCs was 147,493 and 81,705, respectively.Investigator reported best responses were 5 CR, 2 PR, 5 SD, and 17 PD.A combination of high T cell infiltration and clonality in tumors correlated with CR/PR compared to PD (p=0.02232, OR 11.5). The number of T cell clones in the tumor that expanded in the blood 3 weeks post-treatment was greater in CR/PR than in SD (p=0.01253) or PD pts (p=0.05565). Pts with lower baseline peripheral TCR clonality had improved PFS (p=0.0514) and OS (p=0.0116). Conclusions: In mUC patients treated with atezolizumab, high T cell infiltration and clonality in the tumor plus peripheral expansion of dominant tumor-resident TCR clones were associated with response. Low peripheral TCR clonality was associated with survival. These findings suggest that atezolizumab re-invigorates an oligoclonal population of tumor infiltrating lymphocytes and promotes their expansion in the blood. Low TCR repertoire clonality in the periphery at baseline may aid in preventing immune escape and may lead to improved OS. Similar observations have been seen in mice treated with radiation plus checkpoint blockade (Nature 520:373,2015). These findings warrant further study.
- Open Access
- 23 November 2015
- Published by Springer Nature in Genome Medicine
- Vol. 7 (1) , 123
Annotation of pseudogenic gene segments by massively parallel sequencing of rearranged lymphocyte receptor loci
The adaptive immune system generates a remarkable range of antigen-specific T-cell receptors (TCRs), allowing the recognition of a diverse set of antigens. Most of this diversity is encoded in the complementarity determining region 3 (CDR3) of the β chain of the αβ TCR, which is generated by somatic recombination of noncontiguous variable (V), diversity (D), and joining (J) gene segments. Deletion and non-templated insertion of nucleotides at the D-J and V-DJ junctions further increases diversity. Many of these gene segments are annotated as non-functional owing to defects in their primary sequence, the absence of motifs necessary for rearrangement, or chromosomal locations outside the TCR locus. We sought to utilize a novel method, based on high-throughput sequencing of rearranged TCR genes in a large cohort of individuals, to evaluate the use of functional and non-functional alleles. We amplified and sequenced genomic DNA from the peripheral blood of 587 healthy volunteers using a multiplexed polymerase chain reaction assay that targets the variable region of the rearranged TCRβ locus, and we determined the presence and the proportion of productive rearrangements for each TCRβ V gene segment in each individual. We then used this information to annotate the functional status of TCRβ V gene segments in this cohort. For most TCRβ V gene segments, our method agrees with previously reported functional annotations. However, we identified novel non-functional alleles for several gene segments, some of which were used exclusively in our cohort to the detriment of reported functional alleles. We also saw that some gene segments reported to have both functional and non-functional alleles consistently behaved in our cohort as either functional or non-functional, suggesting that some reported alleles were not present in the population studied. In this proof-of-principle study, we used high-throughput sequencing of the TCRβ locus of a large cohort of healthy volunteers to evaluate the use of functional and non-functional alleles of individual TCRβ V gene segments. With some modifications, our method has the potential to be extended to gene segments in the α, γ, and δ TCR loci, as well as the genes encoding for B-cell receptor chains.
- 23 November 2015
- Published by Springer Nature in Genome Medicine
- Vol. 7 (1) , 123
Open AccessAnnotation of pseudogenic gene segments by massively parallel sequencing of rearranged lymphocyte receptor loci
The adaptive immune system generates a remarkable range of antigen-specific T-cell receptors (TCRs), allowing the recognition of a diverse set of antigens. Most of this diversity is encoded in the complementarity determining region 3 (CDR3) of the β chain of the αβ TCR, which is generated by somatic recombination of noncontiguous variable (V), diversity (D), and joining (J) gene segments. Deletion and non-templated insertion of nucleotides at the D-J and V-DJ junctions further increases diversity. Many of these gene segments are annotated as non-functional owing to defects in their primary sequence, the absence of motifs necessary for rearrangement, or chromosomal locations outside the TCR locus. We sought to utilize a novel method, based on high-throughput sequencing of rearranged TCR genes in a large cohort of individuals, to evaluate the use of functional and non-functional alleles. We amplified and sequenced genomic DNA from the peripheral blood of 587 healthy volunteers using a multiplexed polymerase chain reaction assay that targets the variable region of the rearranged TCRβ locus, and we determined the presence and the proportion of productive rearrangements for each TCRβ V gene segment in each individual. We then used this information to annotate the functional status of TCRβ V gene segments in this cohort. For most TCRβ V gene segments, our method agrees with previously reported functional annotations. However, we identified novel non-functional alleles for several gene segments, some of which were used exclusively in our cohort to the detriment of reported functional alleles. We also saw that some gene segments reported to have both functional and non-functional alleles consistently behaved in our cohort as either functional or non-functional, suggesting that some reported alleles were not present in the population studied. In this proof-of-principle study, we used high-throughput sequencing of the TCRβ locus of a large cohort of healthy volunteers to evaluate the use of functional and non-functional alleles of individual TCRβ V gene segments. With some modifications, our method has the potential to be extended to gene segments in the α, γ, and δ TCR loci, as well as the genes encoding for B-cell receptor chains.
- Open Access
Immunosequencing reveals diagnostic signatures of chronic viral infection in T cell memory
B and T cells expand clonally in response to pathogenic infection, and their descendants, which share the same receptor sequence, can persist for years, forming the basis of immunological memory. While most T cell receptor (TCR) sequences are seen very rarely, ‘public’ TCRs are present in many individuals. Using a combination of high throughput immunosequencing, statistical association of particular TCRs with disease status, and machine learning, we identified of a set of public TCRs that discriminates cytomegalovirus (CMV) infection status with high accuracy. This pathogen-specific diagnostic tool uses a very general assay that relies only on a training cohort coupled with immunosequencing and sophisticated data analysis. Since all memory T cell responses are encoded in the common format of somatic TCR rearrangements, a key advantage of reading T cell memory to predict disease status is that this approach should apply to a wide variety of diseases. The underlying dataset is the largest collection of TCRs ever published, including ∼300 gigabases of sequencing data and ∼85 million unique TCRs across 640 HLA-typed individuals, which constitutes by far the largest such collection ever published. We expect these data to be a valuable public resource for researchers studying the TCR repertoire.
Open AccessImmunosequencing reveals diagnostic signatures of chronic viral infection in T cell memory
B and T cells expand clonally in response to pathogenic infection, and their descendants, which share the same receptor sequence, can persist for years, forming the basis of immunological memory. While most T cell receptor (TCR) sequences are seen very rarely, ‘public’ TCRs are present in many individuals. Using a combination of high throughput immunosequencing, statistical association of particular TCRs with disease status, and machine learning, we identified of a set of public TCRs that discriminates cytomegalovirus (CMV) infection status with high accuracy. This pathogen-specific diagnostic tool uses a very general assay that relies only on a training cohort coupled with immunosequencing and sophisticated data analysis. Since all memory T cell responses are encoded in the common format of somatic TCR rearrangements, a key advantage of reading T cell memory to predict disease status is that this approach should apply to a wide variety of diseases. The underlying dataset is the largest collection of TCRs ever published, including ∼300 gigabases of sequencing data and ∼85 million unique TCRs across 640 HLA-typed individuals, which constitutes by far the largest such collection ever published. We expect these data to be a valuable public resource for researchers studying the TCR repertoire.
- 15 April 2015
- Published by American Society for Microbiology in Journal of Virology
- Vol. 89 (8) , 4517-4526
Dynamics of the Cytotoxic T Cell Response to a Model of Acute Viral Infection
A detailed characterization of the dynamics and breadth of the immune response to an acute viral infection, as well as the determinants of recruitment to immunological memory, can greatly contribute to our basic understanding of the mechanics of the human immune system and can ultimately guide the design of effective vaccines. In addition to neutralizing antibodies, T cells have been shown to be critical for the effective resolution of acute viral infections. We report the first in-depth analysis of the dynamics of the CD8 + T cell repertoire at the level of individual T cell clonal lineages upon vaccination of human volunteers with a single dose of YF-17D. This live attenuated yellow fever virus vaccine yields sterile, long-term immunity and has been previously used as a model to understand the immune response to a controlled acute viral infection. We identified and enumerated unique CD8 + T cell clones specifically induced by this vaccine through a combined experimental and statistical approach that included high-throughput sequencing of the CDR3 variable region of the T cell receptor β-chain and an algorithm that detected significantly expanded T cell clones. This allowed us to establish that (i) on average, ∼2,000 CD8 + T cell clones were induced by YF-17D, (ii) 5 to 6% of the responding clones were recruited to long-term memory 3 months postvaccination, (iii) the most highly expanded effector clones were preferentially recruited to the memory compartment, and (iv) a fraction of the YF-17D-induced clones could be identified from peripheral blood lymphocytes solely by measuring clonal expansion. IMPORTANCE The exhaustive investigation of pathogen-induced effector T cells is essential to accurately quantify the dynamics of the human immune response. The yellow fever vaccine (YFV) has been broadly used as a model to understand how a controlled, self-resolving acute viral infection induces an effective and long-term protective immune response. Here, we extend this previous work by reporting the identity of activated effector T cell clones that expand in response to the YFV 2 weeks postvaccination (as defined by their unique T cell receptor gene sequence) and by tracking clones that enter the memory compartment 3 months postvaccination. This is the first study to use high-throughput sequencing of immune cells to characterize the breadth of the antiviral effector cell response and to determine the contribution of unique virus-induced clones to the long-lived memory T cell repertoire. Thus, this study establishes a benchmark against which future vaccines can be compared to predict their efficacy.
- 15 April 2015
- Published by American Society for Microbiology in Journal of Virology
- Vol. 89 (8) , 4517-4526
Dynamics of the Cytotoxic T Cell Response to a Model of Acute Viral Infection
A detailed characterization of the dynamics and breadth of the immune response to an acute viral infection, as well as the determinants of recruitment to immunological memory, can greatly contribute to our basic understanding of the mechanics of the human immune system and can ultimately guide the design of effective vaccines. In addition to neutralizing antibodies, T cells have been shown to be critical for the effective resolution of acute viral infections. We report the first in-depth analysis of the dynamics of the CD8 + T cell repertoire at the level of individual T cell clonal lineages upon vaccination of human volunteers with a single dose of YF-17D. This live attenuated yellow fever virus vaccine yields sterile, long-term immunity and has been previously used as a model to understand the immune response to a controlled acute viral infection. We identified and enumerated unique CD8 + T cell clones specifically induced by this vaccine through a combined experimental and statistical approach that included high-throughput sequencing of the CDR3 variable region of the T cell receptor β-chain and an algorithm that detected significantly expanded T cell clones. This allowed us to establish that (i) on average, ∼2,000 CD8 + T cell clones were induced by YF-17D, (ii) 5 to 6% of the responding clones were recruited to long-term memory 3 months postvaccination, (iii) the most highly expanded effector clones were preferentially recruited to the memory compartment, and (iv) a fraction of the YF-17D-induced clones could be identified from peripheral blood lymphocytes solely by measuring clonal expansion. IMPORTANCE The exhaustive investigation of pathogen-induced effector T cells is essential to accurately quantify the dynamics of the human immune response. The yellow fever vaccine (YFV) has been broadly used as a model to understand how a controlled, self-resolving acute viral infection induces an effective and long-term protective immune response. Here, we extend this previous work by reporting the identity of activated effector T cell clones that expand in response to the YFV 2 weeks postvaccination (as defined by their unique T cell receptor gene sequence) and by tracking clones that enter the memory compartment 3 months postvaccination. This is the first study to use high-throughput sequencing of immune cells to characterize the breadth of the antiviral effector cell response and to determine the contribution of unique virus-induced clones to the long-lived memory T cell repertoire. Thus, this study establishes a benchmark against which future vaccines can be compared to predict their efficacy.
- 1 September 2014
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 20 (17) , 4540-4548
Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH
Purpose: High-throughput sequencing (HTS) of immunoglobulin heavy-chain genes (IGH) in unselected clinical samples for minimal residual disease (MRD) in B lymphoblastic leukemia (B-ALL) has not been tested. As current MRD-detecting methods such as flow cytometry or patient-specific qPCR are complex or difficult to standardize in the clinical laboratory, sequencing may enhance clinical prognostication. Experimental Design: We sequenced IGH in paired pretreatment and day 29 post-treatment samples using residual material from consecutive, unselected samples from the Children's Oncology Group AALL0932 trial to measure MRD as compared with flow cytometry. We assessed the impact of ongoing recombination at IGH on MRD detection in post-treatment samples. Finally, we evaluated a subset of cases with discordant MRD results between flow cytometry and sequencing. Results: We found clonal IGH rearrangements in 92 of 98 pretreatment patient samples. Furthermore, while ongoing recombination of IGH was evident, index clones typically prevailed in MRD-positive post-treatment samples, suggesting that clonal evolution at IGH does not contribute substantively to tumor fitness. MRD was detected by sequencing in all flow cytometry–positive cases with no false-negative results. In addition, in a subset of patients, MRD was detected by sequencing, but not by flow cytometry, including a fraction with MRD levels within the sensitivity of flow cytometry. We provide data that suggest that this discordance in some patients may be due to the phenotypic maturation of the transformed cell. Conclusion: Our results provide strong support for HTS of IGH to enhance clinical prognostication in B-ALL. Clin Cancer Res; 20(17); 4540–8. ©2014 AACR.
- 1 September 2014
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 20 (17) , 4540-4548
Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH
Purpose: High-throughput sequencing (HTS) of immunoglobulin heavy-chain genes (IGH) in unselected clinical samples for minimal residual disease (MRD) in B lymphoblastic leukemia (B-ALL) has not been tested. As current MRD-detecting methods such as flow cytometry or patient-specific qPCR are complex or difficult to standardize in the clinical laboratory, sequencing may enhance clinical prognostication. Experimental Design: We sequenced IGH in paired pretreatment and day 29 post-treatment samples using residual material from consecutive, unselected samples from the Children's Oncology Group AALL0932 trial to measure MRD as compared with flow cytometry. We assessed the impact of ongoing recombination at IGH on MRD detection in post-treatment samples. Finally, we evaluated a subset of cases with discordant MRD results between flow cytometry and sequencing. Results: We found clonal IGH rearrangements in 92 of 98 pretreatment patient samples. Furthermore, while ongoing recombination of IGH was evident, index clones typically prevailed in MRD-positive post-treatment samples, suggesting that clonal evolution at IGH does not contribute substantively to tumor fitness. MRD was detected by sequencing in all flow cytometry–positive cases with no false-negative results. In addition, in a subset of patients, MRD was detected by sequencing, but not by flow cytometry, including a fraction with MRD levels within the sensitivity of flow cytometry. We provide data that suggest that this discordance in some patients may be due to the phenotypic maturation of the transformed cell. Conclusion: Our results provide strong support for HTS of IGH to enhance clinical prognostication in B-ALL. Clin Cancer Res; 20(17); 4540–8. ©2014 AACR.
- Open Access
- 25 October 2013
- Published by Springer Nature in Nature Communications
- Vol. 4 (1) , 2680
Using synthetic templates to design an unbiased multiplex PCR assay
T and B cell receptor loci undergo combinatorial rearrangement, generating a diverse immune receptor repertoire, which is vital for recognition of potential antigens. Here we use a multiplex PCR with a mixture of primers targeting the rearranged variable and joining segments to capture receptor diversity. Differential hybridization kinetics can introduce significant amplification biases that alter the composition of sequence libraries prepared by multiplex PCR. Using a synthetic immune receptor repertoire, we identify and minimize such biases and computationally remove residual bias after sequencing. We apply this method to a multiplex T cell receptor gamma sequencing assay. To demonstrate accuracy in a biological setting, we apply the method to monitor minimal residual disease in acute lymphoblastic leukaemia patients. A similar methodology can be extended to any adaptive immune locus.
- 25 October 2013
- Published by Springer Nature in Nature Communications
- Vol. 4 (1) , 2680
Open AccessUsing synthetic templates to design an unbiased multiplex PCR assay
T and B cell receptor loci undergo combinatorial rearrangement, generating a diverse immune receptor repertoire, which is vital for recognition of potential antigens. Here we use a multiplex PCR with a mixture of primers targeting the rearranged variable and joining segments to capture receptor diversity. Differential hybridization kinetics can introduce significant amplification biases that alter the composition of sequence libraries prepared by multiplex PCR. Using a synthetic immune receptor repertoire, we identify and minimize such biases and computationally remove residual bias after sequencing. We apply this method to a multiplex T cell receptor gamma sequencing assay. To demonstrate accuracy in a biological setting, we apply the method to monitor minimal residual disease in acute lymphoblastic leukaemia patients. A similar methodology can be extended to any adaptive immune locus.